Abstract:High-intensity focused ultrasound (HIFU) is a non-surgical and noninvasive treatment modality that depends on external ultrasound energy sources that induce focused mass ablation and protein degeneration in the treatment area via thermal energy penetration under the intact skin. We aim in our study to collectively evaluate the safety of HIFU for the treatment of different obstetric and gynecological diseases in the literature. We searched PubMed, Scopus, and Science Direct databases, without restriction on date or language, from the inception of these databases until January 20, 2024. We also examined the references of the included studies in the Mendeley archive for eligible articles. We found a total of 706 studies. After the screening and selection process, 56 participants were included. Our dichotomous outcomes were pooled in our single-arm meta-analysis as risk ratio (RR) and with 95% confidence interval (CI) while our continuous outcomes were pooled as mean change and 95% CIs. Fixed- or random-effects models were applied depending on the heterogeneity detected. Our systematic review and meta-analysis included 56 studies including 11.740 patients. Depending on the Society of Interventional Radiology (SIR) classification for adverse effects. The results of this meta-analysis for the type A category that did not require clinical intervention found that pain in the treatment site estimated RR with 95% CI: 0.61 (0.33, 0.89), abnormal vaginal discharge 0.16 (0.073, 0.24), low-grade fever (<38 °C) 0.005 (0.002, 0.009). Sensory abnormalities of the lower limbs were examined in 3390 individuals and observed in only 19 patients who experienced gradual relief of symptoms within one month after treatment. Regarding SIR type B, 99 of a total of 6.437 patients had small vesicles and superficial burns with pooled RR and 95% CI: 0.012 (0.007, 0.018). In terms of groin or perianal and lower abdominal pain, our RRs with 95% CIs were 0.1 (0.067, 0.13) and 0.38 (0.25, 0.51). However, vaginal bleeding was detected in only 32 out of a total of 3.017. Major adverse events like lumber disc herniation, thrombocytopenia, and renal failure, were unmentionable. Additionally, our included studies did not record any deaths. HIFU, either alone or in combination with oxytocin or any other enhancing agent, is safe for patients with different gynecological and obstetric diseases. In terms of efficacy, it showed promising results compared with traditional treatment lines. To our knowledge, we are the first and most comprehensive meta-analysis in the literature that has studied the different safety outcomes related to HIFU as a treatment modality for different obstetric and gynecological diseases with a very large sample size, making our evidence strong and less attributed to errors.

Novel Non-invasive Treatment With High-intensity Focused Ultrasound (HIFU)

Clinical Effectiveness and Potential Long-Term Benefits of High-Intensity Focused Ultrasound Therapy for Patients with Adenomyosis.

High-Intensity Focused Ultrasound Treatment for Non-Neoplastic Epithelial Disorders of the Vulva

Ultrasound-guided high intensity focused ultrasound for the treatment of gynaecological diseases: A review of safety and efficacy

An Introduction to High Intensity Focused Ultrasound: Systematic Review on Principles, Devices, and Clinical Applications

High-Intensity Focused Ultrasound: Current Status for Image-Guided Therapy

High-intensity focused ultrasound in breast pathology: non-invasive treatment of benign and malignant lesions

High-Intensity Focused Ultrasound: A Review of Mechanisms and Clinical Applications

Extracorporeal high intensity focused ultrasound in the treatment of patients with solid malignancy

Current and future role of HIFU in obstetric gynaecology

Clinical Application of High-intensity Focused Ultrasound in Cancer Therapy

MR-guided high-intensity focused ultrasound: current status of an emerging technology

Effective High Intensity Focused Ultrasound Treatment In Recurrent Aggressive Breast Fibromatosis: A Case Report

Progress in High Intensity Focused Ultrasound Ablation for Fertility Preservation Therapy of Uterine Fibroids and Adenomyosis

An Alternative Treatment for Uterine Fibroids and Adenomyosis: High-intensity Focused Ultrasound

Image-Guided High-Intensity Focused Ultrasound, A Novel Application for Interventional Nuclear Medicine?

[High intensity focused ultrasound (HIFU) : Importance in the treatment of prostate cancer]

How safe is high-intensity focused ultrasound? An intriguing solution for obstetric and gynecological diseases: A systematic review

Study Protocol of a Prospective, Monocentric, Single-Arm Study Investigating the Safety and Efficacy of Local Ablation of Symptomatic Uterine Fibroids with US-Guided High-Intensity Focused Ultrasound (HIFU)

High intensity focused ultrasound therapy for malignant tumors

High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility